Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2021-11-05 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
211105 - Vervreemding van eigen aandelen_NED.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB shares were transferred to employees exercising stock options under various long-term incentive plans. This activity directly relates to the company managing its own share capital, specifically through the disposal or repurchase of treasury shares. The filing category 'Transaction in Own Shares' (POS) is the most appropriate fit for reporting share repurchases or disposals related to employee stock plans. The document is a formal announcement dated November 5, 2021, providing detailed transaction tables, which confirms it is a primary disclosure, not just an announcement of a report (RPA/RNS).
2021-11-05 Dutch
29.10.21-ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposals of own shares" and details transactions where the company disposed of its own shares OTC in connection with the exercise of stock options under its Long Term Incentive Program. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document is a formal announcement/press release, not a comprehensive report, so POS is more specific than RNS.
2021-10-29 English
29.10.21-FR.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Disposal of own shares) and it details transactions where UCB SA disposed of its own shares following the exercise of stock options by employees. This directly corresponds to the definition of a company reporting transactions involving its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a formal announcement dated October 29, 2021, detailing specific transactions that occurred between October 22 and October 28, 2021.
2021-10-29 French
29.10.21-NL.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB shares were transferred to employees as part of long-term incentive plans (stock options). This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation/share schemes. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement (gereglementeerde informatie) detailing specific dates, quantities, and prices of these transactions.
2021-10-29 Dutch
211022 - Disposals of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled "Disposals of own shares" and details transactions where the company disposed of its own shares OTC following stock option exercises for personnel under various LTI Plans. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). This matches the definition for Transaction in Own Shares (POS). The document is a formal announcement dated October 22, 2021, and is classified as "regulated information," indicating a mandatory disclosure related to share capital changes.
2021-10-22 English
211022 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Disposal of own shares) and details transactions where UCB SA alienated (sold/transferred) its own shares following the exercise of options by personnel, as required by Belgian Royal Decree (Article 8:6). This activity specifically relates to the company buying back or issuing its own shares, often as part of compensation or capital management. This aligns directly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities. It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a Director's Dealing (DIRS) as it concerns company-wide employee option exercises rather than individual director trades.
2021-10-22 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.